Cardiff Oncology, Inc.

CRDF Nasdaq SEC CIK 1213037
Follow Cardiff Oncology Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $171K +42.5% vs same quarter last year
Net income −$8.9M +21.3% vs same quarter last year
EPS, diluted −$0.12 +29.4% vs same quarter last year
Operating cash flow −$9.9M +8.9% vs same quarter last year
Revenue by quarter
$151K
$109K
$121K
$120K
$243K
$41K
$104K
$171K
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$40M−$30M−$20M−$10M$0$10MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$593K−$45.9K
FY24$683K−$45.4K
FY23$488K−$41.4K
FY22$386K−$38.7M
FY21$359K−$28.3M
FY20$366K−$19.3M
FY19$244.6K−$16.4M
FY18$378.3K−$16.5M
FY17$505.4K−$24.9M
FY16$381.1K−$39.2M
FY15$312.8K−$27.5M
FY14$280.2K−$14.3M
FY13$259.2K−$11.8M
FY12$450.4K−$11.6M
FY11$257.7K−$2.2M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−15000%−10000%−5000%0%5000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25-−8256.3%−7.7%
FY24-−7123.1%−6.7%
FY23-−9305.7%−8.5%
FY22-−10337.3%−10026.9%
FY21-−8037.6%−7880.5%
FY20-−5214.8%−5275.1%
FY19100%−6817.8%−6709.7%
FY18−57.9%−4507.6%−4351.1%
FY17-−5064.4%−4928.1%
FY16-−10534.9%−10287.7%
FY15−101.1%−8079.5%−8782%
FY1494.5%−5334.2%−5113%
FY13-−4123.7%−4555.9%
FY12-−1076.6%−2567.9%
FY11-−1155.2%−868.9%
Free cash flowOperating cash flow minus capital expenditure
−$40M−$30M−$20M−$10M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$38M
FY24−$37.8M
FY23−$31.5M
FY22−$34.8M
FY21−$23.2M
FY20−$16.5M
FY19−$13.3M
FY18−$13.2M
FY17−$23.4M
FY16−$31.9M
FY15−$24.4M
FY14−$13.1M
FY13−$8M
FY12−$5.2M
FY11−$1.9M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Cardiff Oncology
  • Healthcare median
−15000%−10000%−5000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearCardiff OncologyHealthcare median
FY25−7.7%−30.6%
FY24−6.7%−47%
FY23−8.5%−58%
FY22−10026.9%−80.4%
FY21−7880.5%−71.8%
FY20−5275.1%−62.2%
FY19−6709.7%−46.2%
FY18−4351.1%−49.6%
FY17−4928.1%−45.9%
FY16−10287.7%−36%
FY15−8782%−37.8%
FY14−5113%−35.5%
FY13−4555.9%−37.1%
FY12−2567.9%−29.1%
FY11−868.9%−27.9%